Skip to content

Clinical trials

Fabry Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fabry Disease Country / region: United States Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20024
20034
20044
20051
20064
20072
20082
20092
20105
20116
20124
20132
20144
20152
20164
20171
20187
20193
20204
20212
20224
20235
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56
Recruiting10
Terminated9
Active, not recruiting6
Unknown status6
Withdrawn3
No longer available1
Enrolling by invitation1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amicus Therapeutics18
Genzyme, a Sanofi Company13
National Institute of Neurological Disorders and Stroke (NINDS)11
Chiesi Farmaceutici S.p.A.7
Shire6
Protalix4
Baylor Research Institute3
Massachusetts General Hospital3
O & O Alpan LLC3
Sanofi3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fabry Disease93
Lysosomal Storage Diseases10
Stroke9
Proteinuria6
Gaucher Disease4
Glycogen Storage Disease Type II3
Hypohidrosis3
Kidney Failure, Chronic3
Niemann-Pick Diseases3
Angiokeratoma2

Trials

Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.